Characteristics of Mediastinal Lymph Node With False Positive FDG PET/CT Results in Lung Cancer Staging : Relation With TB and Latent TB Infection

NCT01376856 | Terminated

• 1 other identifier: 4-2011-0196
• Study Type: observational
• Target: 33
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to analyze pathologic and radiologic characteristics of mediastinal lymph nodes with false positive FDG PET/CT results in lung cancer staging and assess relationship between false positive mediastinal lymph node and TB/latent TB.

Conditions

Lung Cancer

Keywords

mediastinal lymph node with false positive FDG PET/CT results in lung cancer staging

Outcome Measures

Primary Outcomes (1)

• false positive rate of Mediastinal Lymph Node

  3months

Study Arms (1)

PET/CT and surgical biopsy group

person who performed PET/CT and surgical biopsy of mediastinal lymph node for diagnosis of primary lung cancer of metastatic lung cancer

Eligibility Criteria

• Age: 20 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

person who performed PET/CT and surgical biposy of mediastinal lymph node for diagnosis of primary lung cancer of metastatic lung cancer

You may qualify if:

• age 20-75, men and women
• person who performed PET/CT and surgical biopsy of mediastinal lymph node for diagnosis of primary lung cancer of metastatic lung cancer

You may not qualify if:

• age \< 20
• person who don't agree with enrollment
• illiterate
• person who is diagnosed as active tuberculosis now
• person who has history of hypersensitivity on PPD (tuberculin purified protein derivative)
• pregnant woman
• person who is treated as active tuberculosis

Sponsors & Collaborators

• Yonsei University: lead

Study Sites (1)

Severance Hospital

Seoul, 120-752, South Korea

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

whole blood for perfoming Quantiferon-TB Gold in tube assay

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Study Design

• Study Type: observational
• Observational Model: CASE CROSSOVER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 16, 2011
• First Posted: June 20, 2011
• Study Start: June 1, 2011
• Primary Completion: November 1, 2011
• Study Completion: November 1, 2011
• Last Updated: June 4, 2013

Record last verified: 2013-06

Locations

KR (1)